Company Filing History:
2 out of 2 
2 out of 2 
1 out of 522 Years Active: 2014-2025
Title: The Innovations of Rongguo Qiu
Introduction
Rongguo Qiu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the development of pharmaceutical preparations. With a total of 4 patents, his work focuses on innovative methods for producing therapeutic compounds.
Latest Patents
One of his latest patents is titled "Recombinant bacteria for producing de-epoxidized epothilone B and use thereof." This invention involves the use of recombinant bacteria to produce de-epoxidized epothilone B through fermentation. It also includes the insertional inactivation of an epoK gene in the epothilone biosynthetic gene cluster within the recombinant bacteria. Another notable patent is "De-epoxidized epothilone derivative preparation, preparation of same and use thereof in the treatment of tumor." This application discloses a pharmaceutical preparation comprising a de-epoxidized epothilone derivative, which is particularly useful in treating solid tumors that are resistant to conventional chemotherapeutic agents.
Career Highlights
Rongguo Qiu has worked with several companies, including Beijing Biostar Technologies, Ltd. and Chengdu Biostar Pharmaceuticals, Ltd. His experience in these organizations has allowed him to advance his research and contribute to the development of innovative medical solutions.
Collaborations
Throughout his career, he has collaborated with notable colleagues such as Li Tang and Chuan Zhang. These partnerships have facilitated the exchange of ideas and fostered advancements in their respective fields.
Conclusion
Rongguo Qiu's contributions to biotechnology and pharmaceutical innovations are noteworthy. His patents reflect a commitment to improving cancer treatment through advanced methodologies. His work continues to impact the medical field positively.